2, exposure time 10 min. On days free from irradiation, no sonodynamic chemotherapy sessions are performed, while 15 procedures of sonodynamic exposure are performed for the entire course of external exposure. The total dose of gemcitabine for the external exposure course is 1500 mg. After the course of irradiation, a break in treatment for 2-3 weeks is performed. Then a course of endovaginal brachytherapy with a fraction dose of 3 Gy with irradiation frequency one day until a cumulative dose of 15 Gy is conducted. On days of irradiation, 2 hours before the irradiation session, a sonodynamic therapy session is performed. For this purpose, the above-mentioned "extempore" composed mixture is introduced into the anus region. Immediately after its delivery, , the radiator is fed to the focal point of the lesion and a medium frequency ultrasonic exposure session is conducted at a frequency of 0.88 MHz, I=1.0 Bm/cm2, exposure time is 10 min. In days free from irradiation, no sonodynamic chemotherapy sessions are performed. A total of 5 procedures are performed for the course of intracavitary irradiation. The total dose of gemcitabine for the course of combined radiation treatment is 2000 mg, total cumulative dose at the primary focus is 61 isoGr.;EFFECT: improved effectiveness of radiation treatment, quality of life of patients with locally advanced anal cancer with transition to the skin, its complete regression.;1 ex, 1 tbl"/>
公开/公告号RU2638616C1
专利类型
公开/公告日2017-12-14
原文格式PDF
申请/专利号RU20160142950
发明设计人 KIT OLEG IVANOVICH;KROKHMAL YULIYA NIKOLAEVNA;ROZENKO LYUDMILA YAKOVLEVNA;SOLNTSEVA ANNA ANATOLEVNA;GUSAREVA MARINA ALEKSANDROVNA;FRANTSIYANTS ELENA MIKHAJLOVNA;
申请日2016-10-31
分类号A61N7/00;A61N5/10;A61M36/10;A61K31/7064;A61K47/36;A61K35/644;A61K51/00;A61P35/00;
国家 RU
入库时间 2022-08-21 12:35:55